The Danish National Diabetes Register: Trends in Incidence, Prevalence and Mortality
Overview
Affiliations
Aims/hypothesis: The aim of the study was to describe trends in the incidence rate, prevalence and mortality rate for diabetes in Denmark.
Methods: Healthcare registers at the National Board of Health were used to compile a register of diabetic patients in the Danish population (5.4 million people). Age- and sex-specific prevalence, incidence rates, mortality rates and standardised mortality ratios relative to the non-diabetic part of the population were calculated.
Results: The register contains records for about 360,000 persons with diabetes; 230,000 were alive at 1 January 2007, corresponding to an overall prevalence of 4.2%. The prevalence increased by 6% per year. In 2004 the incidence rates were 1.8 per 100,000 at age 40 years and 10.0 per 100,000 at age 70 years. The incidence rate increased 5% per year before 2004 and then stabilised. The mortality rate in the diabetic population decreased 4% per year, compared with 2% per year in the non-diabetic part of the population. The mortality rate decreased 40% during the first 3 years after inclusion in the register. The standardised mortality ratio decreased with age, from 4.0 at age 50 years to 2.5 at age 70 years and just under 2 at age 85 years, identically for men and women. The standardised mortality ratio decreased 1% per calendar year. The lifetime risk of diabetes was 30%.
Conclusions/interpretation: The prevalence of diabetes in Denmark rose in 1995-2006, but the mortality rate in diabetic patients decreased faster than that of the non-diabetic population. The mortality rate decreased markedly just after inclusion in the register. Incidence rates have shown a tendency to decrease during the last few years, but this finding should be viewed with caution.
Voeltz D, Vetterer M, Seidel-Jacobs E, Brinks R, Tonnies T, Hoyer A Popul Health Metr. 2024; 22(1):17.
PMID: 39026351 PMC: 11264726. DOI: 10.1186/s12963-024-00337-x.
van der Heide I, Francke A, Dopp C, Heins M, Van Hout H, Verheij R Learn Health Syst. 2024; 8(2):e10392.
PMID: 38633020 PMC: 11019384. DOI: 10.1002/lrh2.10392.
Mortality of type 2 diabetes in Germany: additional insights from Gompertz models.
Kuss O, Baumert J, Schmidt C, Tonnies T Acta Diabetol. 2024; 61(6):765-771.
PMID: 38466430 PMC: 11101541. DOI: 10.1007/s00592-024-02237-w.
Backe M, Jorgensen M, Pedersen M Int J Circumpolar Health. 2023; 82(1):2290305.
PMID: 38055761 PMC: 10997303. DOI: 10.1080/22423982.2023.2290305.
Impact of Intensive Glycemic Treatment on Diabetes Complications-A Systematic Review.
Poonoosamy J, Lopes P, Huret P, Dardari R, Penfornis A, Thomas C Pharmaceutics. 2023; 15(7).
PMID: 37513978 PMC: 10383300. DOI: 10.3390/pharmaceutics15071791.